Massey, N., Vasanthi, S. S., Holtkamp, C., Meyer, C., Rao, N. S., Gimenez-Lirola, L. G., Wang, C., Im, H., Bevoor, A. S., Kannurpatti, S., & Thippeswamy, T. (2025). Mitigating organophosphate nerve agent, soman (GD), induced long-term neurotoxicity: Saracatinib, a Src Tyrosine Kinase inhibitor, as a potential countermeasure. Journal of Neuroinflammation, 22(1). https://doi.org/10.1186/s12974-025-03520-5
Meyer, C, Holtkamp, C, Harm, T, Grego, E, Showman, L, Rao, N S, … Thippeswamy, T (2025). Off-target effects of the NADPH oxidase inhibitor mitoapocynin-encapsulated nanoparticles and free-drug oral treatment in a rat DFP model of neurotoxicity. Journal of Drug Targeting, 1–14. https://doi.org/10.1080/1061186X.2025.2523995
Meyer C, Grego E, S Vasanthi S, Rao NS, Massey N, Holtkamp C, Huss J, Showman L, Narasimhan B, Thippeswamy T. The NADPH Oxidase Inhibitor, Mitoapocynin, Mitigates DFP-Induced Reactive Astrogliosis in a Rat Model of Organophosphate Neurotoxicity. Antioxidants (Basel). 2023 Nov 30;12(12):2061. doi: 10.3390/antiox12122061. PMID: 38136181; PMCID: PMC10740988.
Meyer C, Rao NS, Vasanthi SS, Pereira B, Gage M, Putra M, Holtkamp C, Huss J, Thippeswamy T. Peripheral and central effects of NADPH oxidase inhibitor, mitoapocynin, in a rat model of diisopropylfluorophosphate (DFP) toxicity. Front Cell Neurosci. 2023 Jun 21;17:1195843. doi: 10.3389/fncel.2023.1195843. PMID: 37416507; PMCID: PMC10320212.
